More on Glutathione An extremely powerful antioxidant
If you take other medications in addition to GLP-1 medications, ask about potential interactions with alcohol
At 3 months, semaglutide typically produces 6 to 8% weight loss while tirzepatide produces 7 to 10%
Plasma half-life approximates 68 hours under standard research conditions, meaning 50% of circulating peptide is cleared within that window, 75% within 1216 hours, and greater than 95% within 2448 hours
As more research emerges, understanding of GLP-1 receptor agonists continues to grow and Professor Badve likens them to the ACE inhibitors which similarly underwent a broadening of their list of indications over time
Improvement goals include: Kidney Disease: although as rare as 1 percent, Semaglutide may cause kidney injury leading to kidney failure requiring hemodialysis